DI STEFANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 7.671
EU - Europa 5.964
AS - Asia 4.908
SA - Sud America 582
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 19.191
Nazione #
US - Stati Uniti d'America 7.535
SG - Singapore 2.060
CN - Cina 1.561
IT - Italia 1.360
IE - Irlanda 857
UA - Ucraina 789
GB - Regno Unito 671
SE - Svezia 624
TR - Turchia 543
FR - Francia 533
BR - Brasile 487
DE - Germania 471
IN - India 268
FI - Finlandia 206
VN - Vietnam 204
RU - Federazione Russa 144
CA - Canada 84
HK - Hong Kong 64
PL - Polonia 56
BE - Belgio 46
BD - Bangladesh 39
ES - Italia 38
AR - Argentina 37
AT - Austria 37
JP - Giappone 37
CZ - Repubblica Ceca 35
MX - Messico 34
KR - Corea 24
ZA - Sudafrica 23
IR - Iran 22
NL - Olanda 21
LT - Lituania 20
ID - Indonesia 16
IQ - Iraq 13
EC - Ecuador 12
GR - Grecia 11
EU - Europa 10
PK - Pakistan 10
VE - Venezuela 10
CL - Cile 9
TN - Tunisia 9
MA - Marocco 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
RO - Romania 7
SA - Arabia Saudita 7
CH - Svizzera 6
IL - Israele 6
KE - Kenya 6
AL - Albania 5
AZ - Azerbaigian 5
PY - Paraguay 5
UZ - Uzbekistan 5
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
JO - Giordania 4
PT - Portogallo 4
AU - Australia 3
NP - Nepal 3
PA - Panama 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
EG - Egitto 2
GY - Guiana 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
UY - Uruguay 2
AM - Armenia 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.191
Città #
Singapore 1.533
Chandler 1.123
Jacksonville 928
Dublin 845
Ashburn 464
Southend 460
Dallas 421
Beijing 374
Princeton 373
Chieti 330
Izmir 298
Nanjing 265
Dearborn 228
Santa Clara 216
The Dalles 206
Los Angeles 201
Ann Arbor 200
Wilmington 175
New York 164
Munich 149
Cambridge 146
Altamura 143
Tongling 118
Pescara 107
Nanchang 95
Boardman 87
Buffalo 87
Ho Chi Minh City 71
Shenyang 67
Hong Kong 59
Woodbridge 53
Tianjin 52
São Paulo 51
Hebei 48
Kunming 48
Redondo Beach 48
Brussels 46
Hefei 44
Washington 43
Helsinki 38
Tokyo 36
Rome 34
Warsaw 34
Hanoi 32
Brno 31
Houston 31
Frankfurt am Main 30
Jinan 30
Milan 30
Grevenbroich 29
Kocaeli 29
Dong Ket 28
Zhengzhou 27
Falls Church 26
Jiaxing 26
London 26
Montreal 26
Turku 26
Leawood 25
Nuremberg 25
Seattle 25
Brooklyn 24
Denver 24
Toronto 24
Chicago 23
Vienna 23
Atlanta 22
Augusta 22
Orem 22
Seoul 22
Boston 21
Hangzhou 20
San Mateo 20
Chennai 19
Ningbo 19
Norwalk 19
Stockholm 19
Johannesburg 18
Poplar 18
Mexico City 17
San Francisco 17
Ancona 16
Changsha 16
Bologna 15
Guangzhou 15
Lanciano 15
Ardabil 14
Auburn Hills 14
Lanzhou 14
Silvi 14
Manchester 13
Teramo 13
Kraków 12
Moscow 12
Rio de Janeiro 12
Ankara 11
Brasília 11
Düsseldorf 11
Orange 11
Roubaix 11
Totale 11.673
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 211
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 179
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 173
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 168
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 161
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 160
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 155
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 154
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 152
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 149
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 143
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 143
Synthesis of a novel TRH-related sulphonamido peptide 141
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 141
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 140
NSAID Coniugates for the treatment of Alzheimer's Disease 139
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 137
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 134
Effect of MRJF4 on C6 glioma cells proliferation and migration 134
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 134
Advances in prodrug design for Parkinson's disease 134
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 133
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 131
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 131
Carvacrol codrugs: A new approach in the antimicrobial plan 131
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 130
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 130
Carvacrol prodrugs as novel antimicrobial agents 129
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 128
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 127
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 127
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 127
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 126
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 126
Antiparkinson Prodrugs 125
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 124
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 123
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 122
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 122
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 122
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 122
Carvacrol and its derivatives as antibacterial agents 121
Synthesis and antioxidant properties of novel memantine derivatives 121
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 119
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 119
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 119
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 118
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 118
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 117
Activity of N-(2-phenylethyl)-N-n-propyl-(2-(3-hydroxyphenyl)ethylamine derivates as dopamine receptor ligands 115
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 114
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 114
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 114
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 113
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 113
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 113
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 113
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 112
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 112
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 111
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 111
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 111
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 111
Inside Cover: Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4 ], L121, and Triton X-100 (Chem. Eur. J. 2/2016) 111
Analytical Methods to Best Detect Fluorescent Probe Loading Nanoparticles in Biological Samples 110
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 109
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 109
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 109
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 108
New drug delivery strategies for improved Parkinson’s disease therapy 108
Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination 108
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 108
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 108
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 108
Graphene Oxide increases mammalian spermatozoa fertilizing ability by extracting cholesterol from their membranes and promoting capacitation 107
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 106
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 106
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 106
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 106
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 105
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 105
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 104
Designing Prodrugs for the Treatment of Parkinson's Disease 104
Transdermal donepezil on the treatment of Alzheimer’s disease 104
Synthesis of l-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of l-dopa 104
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 104
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 103
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 103
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 103
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 103
Multiple lipid nanoparticles as antimicrobial drug delivery systems 103
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 102
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 102
In vitro evaluation of the potential anticancer activity of new memantin co-drugs on rat C6 glioblastoma cells 102
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 102
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 102
Novel hydrogels for dispersion of carbon nanotube-based catalysts 101
Epigenetic Memory of Early-Life Parental Perturbation: Dopamine Decrease and DNA Methylation Changes in Offspring 101
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 101
Twin amides as potential prodrugs of L-DOPA 100
Totale 12.132
Categoria #
all - tutte 83.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021722 0 0 0 0 0 214 31 24 92 151 136 74
2021/2022918 33 32 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.486 99 82 102 54 94 461 318 55 20 24 27 150
2024/20253.806 192 720 616 122 50 225 100 199 312 170 472 628
2025/20263.480 684 363 737 909 693 94 0 0 0 0 0 0
Totale 19.805